Stable angina in Spain and its impact on quality of life. The AVANCE registry;Estudio de la angina estable en España y su impacto en la calidad de vida del paciente. Registro AVANCE

Revista Espanola de Cardiologia

Volumn 65, Issue 8, 2012, Pages 734-741

  Borrás, Xavier ^a   Garcia Moll, Xavier ^a   Gómez Doblas, Juan José ^b   Zapata, Antonio ^c   Artigas, Remei ^c  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^c Laboratorios Menarini SA   (Spain)

Author keywords

Antianginal treatment; Chronic ischemic heart disease; Quality of life; Stable angina

Indexed keywords

AGED; ARTICLE; CROSS-SECTIONAL STUDY; DISEASE REGISTRY; DISEASE SEVERITY; FEMALE; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBSERVATIONAL STUDY; OUTPATIENT DEPARTMENT; QUALITY OF LIFE; QUESTIONNAIRE; RECURRENT DISEASE; SPAIN; STABLE ANGINA PECTORIS;

AGED; ANALYSIS OF VARIANCE; ANGINA, STABLE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; REGISTRIES; SAMPLE SIZE; SPAIN;

EID: 84864135052     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/j.recesp.2012.03.011     Document Type: Article

References (23)

1. C. García-García, G. Sanz, V. Valle, L. Molina, J. Sala, and I. Subirana Evolución de la mortalidad intrahospitalaria y el pronóstico a seis meses de los pacientes con un primer infarto agudo de miocardio. Cambios en la última década Rev Esp Cardiol 63 2010 1136 1144
2. H.J. Dargie, I. Ford, K.M. Fox Total Ischemic Burden European Trial (TIBET) Effects of ischaemia and treatment with atenolol, nifedipine SR and their combination on outcome in patients with chronic stable angina. The TIBET Study Group Eur Heart J 17 1996 104 112
3. C.J. Pepine, E.M. Handberg, R.M. Cooper-DeHoff, R.G. Marks, P. Kowey, F.H. Messerli INVEST Investigators A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial JAMA 290 2003 2805 2816
4. S.J. Pocock, T.C. Clayton, R. Knight, K.A. Fox, D.G. Julian, and D.A. Chamberlain Second Randomized Intervention Treatment of Angina (RITA-2) Trial Participants. 7 year outcome in the RITA-2 trial: coronary angioplasty versus medical therapy J Am Coll Cardiol 42 2003 1161 1170
5. W.E. Boden, R.A. O'Rourke, K.K. Teo, P.M. Hartigan, D.J. Maron, W.J. Kostuk COURAGE Trial Research Group Optimal medical therapy with or without PCI for stable coronary disease N Engl J Med 356 2007 1503 1516
6. C.A. Daly, F. Clemens, J.L. Sendon, L. Tavazzi, E. Boersma, N. Danchin Euro Heart Survey Investigators The clinical characteristics and investigations planned in patients with stable angina presenting to cardiologists in Europe: from the Euro Heart Survey of Stable Angina Eur Heart J 26 2005 996 1010
7. K. Fox, M.A. Garcia, D. Ardissino, P. Buszman, P.G. Camici, and F. Crea Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology; ESC Committee for Practice Guidelines (CPG). Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology Eur Heart J 27 2006 1341 1381
8. K. Fox, M.A. Garcia, D. Ardissino, P. Buszman, P.G. Camici, and F. Crea Guía sobre el manejo de la angina estable. Versión resumida Rev Esp Cardiol 59 2006 919 970
9. Organización Mundial de la Salud. The Atlas of Heart Disease and Stroke, 2004 [consultado 22 Sep 2011]. Disponible en: http://www.who.int/ cardiovascular-diseases/en/cvd-atlas-13-coronaryHD.pdf
10. J.A. Spertus, J.A. Winder, T.A. Dewhurst, R.A. Deyo, J. Prodzinski, and M. McDonell Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease J Am Coll Cardiol 25 1995 333 341
11. J.E. Ware Jr., M. Kosinski, and S.D. Keller A 12-Item Short-Form Health Survey (SF-12): construction of scales and preliminary tests of reliability and validity Med Care 32 1996 220 233
12. L. López-Bescós, J. Cosín, R. Elosua, A. Cabadés, M. De los Reyes, F. Arós en nombre de los investigadores del estudio PANES Prevalencia de angina y factores de riesgocardiovascular en las diferentes comunidades autónomas de España: estudio PANES Rev Esp Cardiol 52 1999 1045 1056
13. V. Bertomeu, A. Cordero, J. Quiles, P. Mazón, J. Aznar, and H. Bueno Control de los factores de riesgo y tratamiento de la cardiopatía isquémica: Registro TRECE Rev Esp Cardiol 62 2009 807 811
14. J.A. De Velasco, J. Cosín, J.L. López Sendón, E. De Teresa, M. De Oya, and J.L. Carrasco La prevención secundaria del infarto de miocardio en España. Estudio PREVESE Rev Esp Cardiol 50 1997 406 415
15. EUROASPIRE Study Group EUROASPIRE. A European Society of Cardiology survey of secondary prevention of coronary heart disease: Principal results Eur Heart J 18 1997 1569 1582
16. J.A. De Velasco, E. Llargués, R. Fitó, J. Sala, A. Del Río, and E. Enrique de los Arcos Prevalencia de los factores de riesgo y tratamiento farmacológico al alta hospitalaria en el paciente coronario. Resultados de un registro multicéntrico nacional (Programa 3C) Rev Esp Cardiol 54 2001 159 168
17. J.A. De Velasco, J. Cosín, J. López-Sendón, E. De Teresa, M. De Oya, and G. Sellers Nuevos datos sobre la prevención secundaria del infarto de miocardio en España. Resultados del estudio PREVESE II Rev Esp Cardiol 55 2002 801 809
18. EUROASPIRE Study Group Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries. Principal results from EUROASPIRE II. Euro Heart Survey Programme Eur Heart J 22 2001 554 572
19. K. Kotseva, D. Wood, G. De Backer, D. De Bacquer, K. Pyörä lä, U. Keil EUROASPIRE S EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries Eur J Cardiovasc Prev Rehabil 16 2009 121 137
20. J.F. Beltrane, A.J. Weekes, C. Morgan, R. Tavella, and J.A. Spertus The prevalence of weekly angina among patients with chronic stable angina in primary care practices.The Coronary Artery Disease in General Practice (CADENCE) Study Arch Intern Med 169 2009 1491 1499
21. A.M. Garrat, A. Hutchinson, and I. Russell Network for Evidence-Based Practice in Northern and Yorkshire (NEBPINY). The UK version of the Seattle Angina Questionnaire (SAQ-UK): reliability, validity and responsiveness J Clin Epidemiol 54 2001 907 915
22. F.C. Wiest, C.L. Bryson, M. Burman, M.B. McDonell, J.G. Henikoff, and S.D. Fihn Suboptimal pharmacotherapeutic management of chronic stable angina in the primary care setting Am J Med 117 2004 234 241
23. J.A. Spertus, P. Jones, M. McDonell, V. Fan, and S.D. Fihn Health status predicts long-term outcome in outpatients with coronary disease Circulation 106 2002 43 49